Abstract: The present disclosure provides a satellite system with orbital debris avoidance. In one embodiment, the satellite system includes debris sensor circuitry to scan orbital debris items in an orbital debris field; and sensor controller circuitry to determine a search window within the orbital debris field based on, at least, uncertainties associated with a velocity of the satellite (Vsatellite) and uncertainties associated with a velocity of at least one debris item (Vdebris), the sensor controller circuitry also to control the debris sensor circuitry to detect the at least one debris item within the search window.

Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.

Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.

Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.

Abstract: The present invention relates to the use of compounds in the treatment of inflammation, preferably inflammation associated with activation of Toll-like receptors. The invention also relates to the use of compounds to treat pathogen-induced inflammation.

Abstract: A compound of general formula (I) wherein X, Y, n, p, q, and R1-R17 take various meanings, for use in the treatment of Coronavirus infection.

Abstract: The use of PLD with one or more further CoV antiviral agent(s) in the treatment of coronavirus (CoV) infection.

Abstract: The present invention relates to the use of compounds in the treatment of autoimmune conditions, and in particular, for the treatment of rheumatoid arthritis.

Abstract: The present invention relates to the use of compounds in the treatment of a viral infection, wherein the virus is selected from the Orthomyxoviridae family or wherein the virus is West Nile virus.

Abstract: Provided are methods for the treatment of SCLC patients by administering therapeutic amounts of lurbinectedin by intravenous infusion. Also provided are methods of treating cancer by administering lurbinectedin in combination with other anticancer drugs, in particular topoisomerase inhibitors. The invention further relates to the administration of lurbinectedin in combination with anti-emetic agents for effective control of symptoms related to nausea and vomiting, reduced lurbinectedin dosages to achieve a safer administration and an increase in the number of treatment cycles. Stable lyophilized formulations of lurbinectedin are also provided.

Abstract: A planar transformer including a planar first primary coil; a planar first secondary coil inductively coupled with the first primary coil; and a transformer magnetic core for guiding a magnetic flux generated by the first primary coil and/or the first secondary coil around at least a first opening of the transformer magnetic core. The first primary coil and the first secondary coil are coiled around the transformer magnetic core through the first opening. The first primary coil and the first secondary coil are arranged on a first plane. The embodiments further refer to a battery charger including such a planar transformer.

Abstract: This invention relates to methods for identifying sunflower plants that having increased Orobanche resistance. The methods use molecular markers to identify and to select plants with increased Orobanche resistance. Maize plants generated by the methods of the invention are also a feature of the invention.

Abstract: This invention relates to methods for identifying sunflower plants that having increased Orobanche resistance. The methods use molecular markers to identify and to select plants with increased Orobanche resistance.

Abstract: The invention relates to a sunflower oil with high heat stability, which is characterized in that between 15% and 45% of the fatty acid total are saturated fatty acids (palmitic acid and stearic acid), between 45% and 75% of the fatty acid total is oleic acid and more than 85% of the tocopherol total corresponds to the sum of gamma-tocopherol and delta-tocopherol. The invention also relates to sunflower seeds that contain an oil with the aforementioned characteristics and sunflower plants which as a result of self-pollination produce seeds with the aforementioned characteristics. In addition, the invention relates to the use of said oil in food and animal feed and for the formulation of biolubricants and biofuels.

Abstract: This invention advances the related state-of-the-art by eliminating the physical EO window used by electro-optical imaging infrared seekers for tactical missiles and high-altitude endo-atmospheric interceptors, widely employed in integrated defense systems. This invention increases the probability of intercepting exo-atmospheric ballistic warheads by exo-atmospheric interceptors, and eliminates the existing altitude “gap” of interception, as well as the geographical limitations posed by the mesospheric Noctilucent Clouds. The problem of protecting an imaging EO sensor from aeroheating is solved in this invention by a special purpose device which is enabled immediately after the nose cone ejection event.

Abstract: The present invention belongs to the field of binder compositions for construction, more specifically it relates to the use of carboxymethylchitosan as flocculating additive and setting accelerator in binder compositions of the cement, cement mortar, concrete, grout, stucco and similar type. The invention also relates to binder compositions comprising carboxymethylchitosan, as well as to the method for their preparation.

Abstract: This invention advances the related state-of-the-art by eliminating the physical EO window used by electro-optical imaging infrared seekers for tactical missiles and high-altitude endo-atmospheric interceptors, widely employed in integrated defense systems. This invention increases the probability of intercepting exo-atmospheric ballistic warheads by exo-atmospheric interceptors, and eliminates the existing altitude “gap” of interception, as well as the geographical limitations posed by the mesospheric Noctilucent Clouds. The problem of protecting an imaging EO sensor from aeroheating is solved in this invention by a special purpose device which is enabled immediately after the nose cone ejection event.

Abstract: The invention relates to bread having improved texture and taste and to the method for producing same, specifically to a bread obtained from wheat flour, having a reddish, crunchy crust, and prepared from pieces of precooked dough kept frozen until final baking, and to said pieces of precooked dough. The pieces of precooked dough are obtained from a dough that is a mixture of wheat flour, water, salt, liquid yeast and an improver comprising less than 5% of both hemicellulase and alpha-amylase, and of ascorbic acid and L-cysteine, by means of a method that includes kneading, resting, shaping, fermenting, cutting to form the slit, precooking and chilling. The precooked dough is preferably kept frozen until the bread is to be consumed, at which time it is baked at a temperature higher than usual for 2 minutes to 3 minutes 30 seconds.

Abstract: The present invention relates to the process of obtaining reconstituted foods from natural raw materials and the products obtained following said process. It relates particularly to the process of producing a reconstituted product comprising two concentrically distributed portions such that the outer portion comprises reconstituted olive and the inner portion comprises reconstituted pepper.

Abstract: The invention relates to a novel microalga species and to the use thereof for animal and/or human consumption and in the production of carotenoids. A novel strain of Scenedesmus has been isolated at the Las Palmerillas experimental station, Cajamar, identified as microorganisms that had not been previously registered by the University of Gottinghem and deposited within the Culture Collection of Alagae and Protozoa (CCAP) as Scenedesmus almeriensis. The novel strain, which can be used for animal and/or human consumption, produces large quantities of carotenoids, particularly lutein and beta-carotene. Scenedesmus almeriensis grows adequately in a wide range of temperatures from 10° C. to 40° C. at a pH of between 7 and 9.5 and can tolerate high concentrations of copper, up to 1 mg/L. The microalgal strain is grown in a 4000 L photobioreactor, into which the culture is inserted mechanically, and produces less than 4 mg of lutein per gram of dry material.